Ocugen Inc.

OCGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.03

-$0.03 (-2.83%)

At close: Sep 21, 2026, 4:00 PM ET

$1.04

+$0.01 (+0.97%)

Pre-market: Sep 22, 2026, 8:39 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.83%

(1D)

Rating

Updated: Aug 10, 2026

39.5

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $349.28M

1D Range

1.02 1.08

52W Range

0.97 2.73

Valuation (TTM)

PE -4.12

PB -21.10

EV/EBITDA -4.74

Valuation (NTM)

Forward PE 431.57

Forward PEG -0.53

Price Target $5

Cash Flow

FCF Yield -17.6%

SBC Adj. FCF Yield -20.2%

SBC Impact -15.0%

Margins

Gross Margin 100.0%

Operating Margin -1504.4%

FCF Margin -1340.1%

Growth (CAGR)

Revenue 3Y | 5Y 70.3% | 29.3%

Dil EPS 3Y | 5Y -16.7% | 10.1%

FCF 3Y | 5Y -6.2% | 0.7%

Returns

ROA -65.9%

ROE 1688.2%

ROIC -92.7%

Financial Health

Net Cash

$13.79M

Current Ratio 0.80

Interest Coverage -8.16

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Ocugen, Inc. is a biopharmaceutical company in the clinical development phase, primarily dedicated to pioneering gene therapies aimed at treating various ophthalmic conditions leading to blindness. Th...

Sector Healthcare

Industry Biotechnology

Employees 116

IPO Date Dec 2, 2014

Website www.ocugen.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+385.44%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞